BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37178096)

  • 1. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
    Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
    Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.
    Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G
    Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of post-thaw infused cell dose for predicting engraftment after unrelated cord blood transplantation].
    Wu JY; Liao C; Chen JS; Xu ZP; Li Y; Sun X; Wu SQ; Tang XW; Lu Y; Xie GE
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):754-8. PubMed ID: 21729565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreserved CD34
    Konuma T; Kato S; Oiwa-Monna M; Tanoue S; Ogawa M; Isobe M; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1142-1150. PubMed ID: 28390987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD).
    Facchin G; Savignano C; Battista ML; Isola M; De Martino M; Petruzzellis G; Rosignoli C; Pizzano U; Cerno M; De Cecco G; Bertone A; Barillari G; Fanin R; Patriarca F
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cryopreservation on engraftment kinetics in fully matched allogeneic stem cell transplantation: Real-life data and literature review.
    Ersal T; Özkocaman V; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Koca TG; Pınar İE; Hunutlu FÇ; Özkalemkaş F
    Transfus Apher Sci; 2023 Dec; 62(6):103821. PubMed ID: 37775358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
    Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
    J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution.
    Clarke DM; Yadock DJ; Nicoud IB; Mathew AJ; Heimfeld S
    Cytotherapy; 2009; 11(4):472-9. PubMed ID: 19499402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cell concentration, time of fresh storage, and cryopreservation on peripheral blood stem cells: PBSC fresh storage and cryopreservation.
    Araújo AB; Salton GD; Angeli MH; Furlan JM; Schmalfuss T; Röhsig LM
    Transfus Apher Sci; 2022 Feb; 61(1):103298. PubMed ID: 34696981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of different cryopreservation time on quality of umbilical cord blood cells].
    Huang L; Song GQ; Wu Y; Wang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):177-80. PubMed ID: 23484715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fresh or Cryopreserved CD34
    Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
    Guo M; Liu J; Clark P; Ahmad S; Patel R; Varela JC; Mori S
    Int J Hematol; 2023 Mar; 117(3):428-437. PubMed ID: 36378406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.